Giuseppe Orlando to Time Factors
This is a "connection" page, showing publications Giuseppe Orlando has written about Time Factors.
Connection Strength
0.371
-
Orlando G, Sabbà C, De Liguori Carino N, Scelzo C, Tariciotti L, Bonanni L, D'Angelo M, Baiocchi L, Lerut J, Tisone G. Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report. Liver Int. 2008 Apr; 28(4):574-7.
Score: 0.050
-
Orlando G, Baiocchi L, Cardillo A, Iaria G, De Liguori Carino N, De Liguori N, De Luca L, Ielpo B, Tariciotti L, Angelico M, Tisone G. Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension. Liver Transpl. 2007 Jan; 13(1):46-54.
Score: 0.048
-
Orlando G, Ferrant A, Schots R, Goffette P, Mathijs J, Lemaire J, Danse E, Talpe S, Latinne D, Lerut J. Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int. 2005 Jan; 18(1):125-9.
Score: 0.042
-
Pasha S, Flynn JM, Sponseller PD, Orlando G, Newton PO, Cahill PJ. Timing of Changes in Three-Dimensional Spinal Parameters After Selective Thoracic Fusion in Lenke 1 Adolescent Idiopathic Scoliosis: Two-Year Follow-up. Spine Deform. 2017 11; 5(6):409-415.
Score: 0.025
-
Stratta RJ, Farney AC, Palanisamy A, Rogers J, Orlando G, Reeves-Daniel A. Single-Center Experience with Deceased Donor Kidney Transplantation in 114 Individuals Aged 70 and Older in the New Millennium. J Am Geriatr Soc. 2016 11; 64(11):e219-e221.
Score: 0.024
-
Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. 2016 Jan; 100(1):194-202.
Score: 0.022
-
Ortona E, Colasanti T, Derme M, Iannini I, Vomero M, Sorice M, D'Alessandro F, Costa AN, Malorni W, Orlando G, Framarino-dei-Malatesta M. Serum Antiphospholipid Antibodies in Transplanted Patients: Potential Follow-up Markers to Assess Pregnancy Risk? Transplantation. 2015 Sep; 99(9):e152-4.
Score: 0.022
-
Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int. 2015 Sep; 88(3):584-92.
Score: 0.021
-
Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ. Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. J Nephrol. 2015 Jun; 28(3):379-85.
Score: 0.021
-
Sanders BP, Orlando G, Peloso A, Katari RS, Iskandar SS, Farney AC, Rogers J, Soker S, Stratta RJ. Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles. Exp Clin Transplant. 2014 Aug; 12(4):371-3.
Score: 0.020
-
Pareta R, McQuilling JP, Sittadjody S, Jenkins R, Bowden S, Orlando G, Farney AC, Brey EM, Opara EC. Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats. Pancreas. 2014 May; 43(4):605-13.
Score: 0.020
-
Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int. 2013 Mar; 26(3):259-66.
Score: 0.018
-
Manzia TM, Bellini MI, Corona L, Toti L, Fratoni S, Cillis A, Orlando G, Tisone G. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Transpl Int. 2011 Aug; 24(8):e69-70.
Score: 0.016
-
Baiocchi L, Angelico M, De Luca L, Ombres D, Anselmo A, Telesca C, Orlando G, D'Andria D, Tisone G. Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transpl Int. 2006 May; 19(5):389-95.
Score: 0.011
-
Lerut JP, Orlando G, Sempoux C, Ciccarelli O, Van Beers BE, Danse E, Horsmans Y, Rahier J, Roggen F. Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation. Transpl Int. 2004 May; 17(4):202-7.
Score: 0.010